Zevra Therapeutics (ZVRA) Change in Inventory (2022 - 2026)
Zevra Therapeutics (ZVRA) reported Change in Inventory of $185000.0 for Q1 2026, down 9.76% on a YoY basis from $205000.0 in Q1 2025, and down 64.76% quarter-over-quarter from $525000.0 in Q4 2025.
Zevra Therapeutics (ZVRA) Change in Inventory (2022 - 2026) Analysis & Trends
Zevra Therapeutics has reported Change in Inventory for 5 years, with the latest figure at $185000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Inventory fell 9.76% year-over-year to $185000.0; the trailing twelve-month figure through Mar 2026 stood at $1.3 million (down 80.21% YoY), and the FY2025 full-year result was $1.3 million, down 85.29% from the prior year.
- Change in Inventory for Q1 2026 stood at $185000.0, down from $525000.0 in the prior quarter.
- The five-year high for Change in Inventory was $4.7 million in Q4 2024, with the low at -$241000.0 in Q3 2022.
- Historically, Change in Inventory has averaged $625687.5 across 5 years, with a median of $189500.0 in 2025.
- Annual changes were most pronounced in 2023 — Change in Inventory tumbled 112.03% — and 2024, when it surged 29568.75%.
- Zevra Therapeutics' Change in Inventory stood at $133000.0 in 2022, then plunged by 112.03% to -$16000.0 in 2023, then surged by 29568.75% to $4.7 million in 2024, then slumped by 88.87% to $525000.0 in 2025, then plunged by 64.76% to $185000.0 in 2026.
- The last three Change in Inventory figures came in at $185000.0 (Q1 2026), $525000.0 (Q4 2025), and $194000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 51,468.00 |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 97.70 Mn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Zevra Therapeutics | 796.95 Mn | 596.33 Mn | 34.30 Mn | 185,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 185,000.00 |
| Mar 31, 2026 | 185,000.00 |
| Dec 31, 2025 | 525,000.00 |
| Dec 31, 2025 | 525,000.00 |
| Sep 30, 2025 | 194,000.00 |
| Sep 30, 2025 | 194,000.00 |
| Jun 30, 2025 | 381,000.00 |
| Jun 30, 2025 | 381,000.00 |
| Mar 31, 2025 | 205,000.00 |
| Mar 31, 2025 | 205,000.00 |
| Dec 31, 2024 | 4.72 Mn |
| Dec 31, 2024 | 4.72 Mn |
| Sep 30, 2024 | 583,000.00 |
| Sep 30, 2024 | 583,000.00 |
| Jun 30, 2024 | 991,000.00 |
| Jun 30, 2024 | 991,000.00 |
| Mar 31, 2024 | 2.59 Mn |
| Mar 31, 2024 | 2.59 Mn |
| Dec 31, 2023 | -16,000.00 |
| Dec 31, 2023 | -16,000.00 |